Endocrinology, Vol 137, 257-265, Copyright © 1996 by Endocrine Society

ARTICLES

Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases

FK Hamra, X Fan, WJ Krause, RH Freeman, DT Chin, CE Smith, MG Currie and LR Forte
Truman VA Medical Center, Columbia, Missouri, USA.

Uroguanylin and guanylin are peptides isolated from urine and intestinal mucosa, which regulate cyclic GMP production in enterocytes by activating an apical membrane, receptor-guanylate cyclase. This study extended our previous findings, which showed that colonic mucosa of opossums contained uroguanylin and guanylin peptides, by purifying prouroguanylin and proguanylin from this tissue. Prouroguanylin and proguanylin coeluted from Sephadex G-75 gelfiltration columns with a similar molecular size between 6 and 12 kDa. Mass spectrometry indicated that proguanylin (approximately 8.7 kDa) had a 10% lower molecular mass than prouroguanylin (approximately 9.7 kDa). Isoelectric focusing separated prouroguanylin (pI approximately 4.5) from proguanylin (pI approximately 7.5). N-terminal sequence analysis of reverse phrase-HPLC purified prohormones revealed 13 amino acids in opossum proguanylin that shared 77-85% identity with human and rat proguanylin, but only 23% identity with opossum prouroguanylin. The N- terminal 19 residues obtained for opossum prouroguanylin shared 32-42% identity with rat and human proguanylin. Prouroguanylin and proguanylin were both inactive and required pretreatment with proteases to elicit cyclic GMP responses in T84 cells. V8 protease treatment of proguanylin liberated a bioactive, 16-amino acid form of guanylin. Chymotrypsin treatment activated prouroguanylin, but inactivated the bioactive peptide domain within proguanylin. In summary, colonic mucosa contains the bioactive peptide and inactive prohormone forms of uroguanylin and guanylin. Thus, after proteolytic processing of prouroguanylin and proguanylin, bioactive uroguanylin and guanylin could both function to regulate guanylate cyclase activity by autocrine and/or paracrine actions on enterocytes. Also, these peptide hormones are implicated in an intestinal-renal axis for the endocrine regulation of salt and water homeostasis.

This article has been cited by other articles:

				N. G. Moss, D. A. Riguera, R. M. Solinga, M. M. Kessler, D. P. Zimmer, W. J. Arendshorst, M. G. Currie, and M. F. Goy The Natriuretic Peptide Uroguanylin Elicits Physiologic Actions Through 2 Distinct Topoisomers Hypertension, May 1, 2009; 53(5): 867 - 876. [Abstract] [Full Text] [PDF]

				X. Qian, N. G. Moss, R. C. Fellner, and M. F. Goy Circulating Prouroguanylin Is Processed to Its Active Natriuretic Form Exclusively within the Renal Tubules Endocrinology, September 1, 2008; 149(9): 4499 - 4509. [Abstract] [Full Text] [PDF]

				N. G. Moss, R. C. Fellner, X. Qian, S. J. Yu, Z. Li, M. Nakazato, and M. F. Goy Uroguanylin, an Intestinal Natriuretic Peptide, Is Delivered to the Kidney as an Unprocessed Propeptide Endocrinology, September 1, 2008; 149(9): 4486 - 4498. [Abstract] [Full Text] [PDF]

				A. Sindic and E. Schlatter Mechanisms of action of uroguanylin and guanylin and their role in salt handling Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3007 - 3012. [Full Text] [PDF]

				A. Sindic and E. Schlatter Cellular Effects of Guanylin and Uroguanylin J. Am. Soc. Nephrol., March 1, 2006; 17(3): 607 - 616. [Abstract] [Full Text] [PDF]

				S. Yuge, K. Inoue, S. Hyodo, and Y. Takei A Novel Guanylin Family (Guanylin, Uroguanylin, and Renoguanylin) in Eels: POSSIBLE OSMOREGULATORY HORMONES IN INTESTINE AND KIDNEY J. Biol. Chem., June 13, 2003; 278(25): 22726 - 22733. [Abstract] [Full Text] [PDF]

				J. A. Rudolph, J. A. Hawkins, and M. B. Cohen Proguanylin secretion and the role of negative-feedback inhibition in a villous epithelial cell line Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G695 - G702. [Abstract] [Full Text] [PDF]

				A. Sindice, C. Basoglu, A. Cerci, J. R. Hirsch, R. Potthast, M. Kuhn, Y. Ghanekar, S. S. Visweswariah, and E. Schlatter Guanylin, Uroguanylin, and Heat-stable Euterotoxin Activate Guanylate Cyclase C and/or a Pertussis Toxin-sensitive G Protein in Human Proximal Tubule Cells J. Biol. Chem., May 10, 2002; 277(20): 17758 - 17764. [Abstract] [Full Text] [PDF]

				F. Moro, F. Levenez, E. Nemoz-Gaillard, S. Pellissier, P. Plaisancie, and J. C. Cuber Release of Guanylin Immunoreactivity from the Isolated Vascularly Perfused Rat Colon Endocrinology, July 1, 2000; 141(7): 2594 - 2599. [Abstract] [Full Text] [PDF]

				S. L. Carrithers, S. L. Eber, L. R. Forte, and R. N. Greenberg Increased urinary excretion of uroguanylin in patients with congestive heart failure Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H538 - H547. [Abstract] [Full Text] [PDF]

				L. R. Forte, R. M. London, R. H. Freeman, and W. J. Krause Guanylin peptides: renal actions mediated by cyclic GMP Am J Physiol Renal Physiol, February 1, 2000; 278(2): F180 - F191. [Abstract] [Full Text] [PDF]

				L. R. Forte, S. L. Eber, X. Fan, R. M. London, Y. Wang, L. M. Rowland, D. T. Chin, R. H. Freeman, and W. J. Krause Lymphoguanylin: Cloning and Characterization of a Unique Member of the Guanylin Peptide Family Endocrinology, April 1, 1999; 140(4): 1800 - 1806. [Abstract] [Full Text]

				M. Nakazato, H. Yamaguchi, Y. Date, M. Miyazato, K. Kangawa, M. F. Goy, N. Chino, and S. Matsukura Tissue Distribution, Cellular Source, and Structural Analysis of Rat Immunoreactive Uroguanylin Endocrinology, December 1, 1998; 139(12): 5247 - 5254. [Abstract] [Full Text] [PDF]

				M. C. Fonteles, R. N. Greenberg, H. S. A. Monteiro, M. G. Currie, and L. R. Forte Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney Am J Physiol Renal Physiol, August 1, 1998; 275(2): F191 - F197. [Abstract] [Full Text] [PDF]

				X. Fan, Y. Wang, R. M. London, S. L. Eber, W. J. Krause, R. H. Freeman, and L. R. Forte Signaling Pathways for Guanylin and Uroguanylin in the Digestive, Renal, Central Nervous, Reproductive, and Lymphoid Systems Endocrinology, November 1, 1997; 138(11): 4636 - 4648. [Abstract] [Full Text] [PDF]

				X. Fan, F. K. Hamra, R. M. London, S. L. Eber, W. J. Krause, R. H. Freeman, C. E. Smith, M. G. Currie, and L. R. Forte Structure and activity of uroguanylin and guanylin from the intestine and urine of rats Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E957 - E964. [Abstract] [Full Text] [PDF]

				F. K. Hamra, S. L. Eber, D. T. Chin, M. G. Currie, and L. R. Forte Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity PNAS, March 18, 1997; 94(6): 2705 - 2710. [Abstract] [Full Text] [PDF]

				Y. Hidaka, C. Shimono, M. Ohno, N. Okumura, K. Adermann, W.-G. Forssmann, and Y. Shimonishi Dual Function of the Propeptide of Prouroguanylin in the Folding of the Mature Peptide. DISULFIDE-COUPLED FOLDING AND DIMERIZATION J. Biol. Chem., August 11, 2000; 275(33): 25155 - 25162. [Abstract] [Full Text] [PDF]